Healogics, the nation’s leading provider of world-class wound care services, is proud to announce the eighth annual Diabetes Awareness Campaign throughout the month of November, which is National Diabetes Awareness Month. The Healogics wound care specialists, at the more than 600 Healogics Wound Care Centers® nationwide, will be raising awareness of the importance of early intervention and specialized care for diabetes-related chronic wounds, such as diabetic foot ulcers … Diabetic foot ulcers are a leading cause of lower-limb amputations and according to the American Diabetes Association, an average of 10 Americans will undergo an amputation due to diabetes every hour. Of the 34.2 million Americans currently living with diabetes, up to 25% may develop a diabetic foot ulcer. These hard-to-heal wounds often go undetected due to the lack of feeling in the lower extremities due to nerve damage caused by diabetes … read more
Tag: Healogics
The HealSource™ Clinical Practice Guidelines
The HealSource™ Clinical Practice Guidelines provide a standardized method for the delivery of care, treatment and services to patients with wounds or ulcers.
These clinical practice guidelines are a useful guide when caring for patients, providing general guidelines for the treatment of chronic wounds and the application of hyperbaric oxygen treatment. The data relies heavily on three significant and highly respected contributions to the fields of wound care and hyperbaric medicine:
The Wound Healing Society guidelines for the best care of chronic wounds
The Wound Ostomy Continence Nurses Society clinical practice guidelines
The Oxygen Therapy Committee Report of the Undersea and Hyperbaric Medicine Society
Healogics® Raises Awareness of Peripheral Artery Disease (PAD) to Help Reduce Amputations
Healogics, the nation’s leading provider of world-class wound care services, is raising awareness of Peripheral Artery Disease (PAD) throughout September. Through this campaign, Healogics is supporting the American Heart Association’s goal to reduce amputations by 20% by 2030 through increased PAD Awareness, diagnosis and treatment … People with PAD often have non-healing wounds in their extremities due to the restriction of blood flow limiting the natural healing process, potentially leading to complications, such as amputation. PAD affects nearly 10 million Americans and is a contributing factor in up to 30% of non-healing wounds on the lower leg. Common symptoms associated with PAD include cramping, numbness, weakness or heaviness in the leg muscles, however up to 40% of people experience no symptoms. One in four people living with late-stage PAD may require amputation within one year … read more
Healogics® Receives Accreditation from American Nurses Credentialing Center
Healogics®, the nation’s leading provider of world-class wound care, is proud to announce its accreditation from the American Nurses Credentialing Center (ANCC) …The ANCC Accreditation Program identifies organizations that exhibit excellence in Nursing Continuing Professional Development (NCPD). In order to be awarded accreditation, rigorous standards must be met for providing continuing professional development to registered nurses. Healogics earned this distinction by promoting excellence in nursing and patient safety, and providing nurses with the knowledge and skills to help improve care and patient outcomes … “We are proud to achieve the highly regarded Accreditation from ANCC,” said Healogics Vice President of Clinical and Quality Process Excellence, Carolyn M. Shinn … Healogics nurses will have the opportunity to participate in the highest level of education to meet certification or licensure requirements, as ANCC-accredited continuing education is the most impressive and viable strategy in improving professional nursing practice … read more
Healogics® Announces New Program Aimed at Improving Continuity of Care
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Aug 30, 2018–Healogics®, the wound healing experts, today announced the launch of their newest program: Healogics Specialty Physicians Care Continuum (HSP Care Continuum). The Program is designed to support the patient experience by improving continuity of care, cost-effectiveness, patient outcomes, value and satisfaction for people with chronic wounds who are transitioning from an inpatient to an outpatient setting.
Healogics Announces New Program Aimed at Improving Continuity of Care
The HSP Care Continuum Program provides skilled wound care physicians in the hospital inpatient setting who have specialized training in the management of complex wounds. These physicians will work collaboratively with Certified Wound and Ostomy Nurses and referring specialists needing a specialty consult. Also, Healogics clinical teams educate discharge planners on post-acute options so patients with wounds receive care for this critical co-morbid condition while they are also receiving post-acute care for their primary diagnosis. Healogics has a vast library of educational content that will be made available for patients who can care for their wounds between follow up post-acute visits.
“The average hospital stay is 2.4 days longer for patients living with a chronic wound. With better inpatient consults, we believe we can have an impact on care continuity and, in turn, reducing the overall cost of care. We are excited for the launch of this new program, and the positive implications it will have on the overall patient experience,” said David Bassin, Healogics Chief Executive Officer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180830005777/en/
Organogenesis Inc. Announces Support of American Diabetes Association
Organogenesis will support initiatives to educate about diabetic foot ulcers, the leading cause of diabetes-related amputations
CANTON, Mass., June 21, 2018 /PRNewswire/ — Organogenesis Inc. – a leading regenerative medicine company committed to empowering healing – today announced it is a proud supporter of the American Diabetes Association (ADA). Organogenesis will support the production of an ADA scientific compendium focused on the latest scientific evidence related to the treatment of diabetic foot ulcers (DFUs), the leading cause of diabetes-related amputations in the United States.
Organogenesis will also host a corporate symposium, “Innovations in Diabetic Wound Healing,” at the ADA’s 78thScientific Sessions, held June 22-26 in Orlando, FL, and exhibit during the meeting trade show at Booth #616.
“As a global regenerative medicine company driven by a shared mission to empower healing, we work to provide opportunities for patients and health care professionals to learn more about state-of-the-art approaches to treat diabetic foot ulcers,” said Gary S. Gillheeney, Sr., President and CEO of Organogenesis. “We are happy to support the ADA and its work to help Americans living with diabetes.”
Healogics settles False Claims allegations
agrees to pay up to $22 million
Healogics has agreed to pay up to $22 million to settle allegations that it knowingly billed Medicare for medically unnecessary therapies, the Justice Department announced Wednesday.
The Jacksonville-based company manages the hyperbaric oxygen therapy centers at more than 700 hospital-based wound care facilities across the country and is one of the largest in the nation. The company has several centers in Central Florida.
According to the Justice Department, between 2010 and 2015 Healogics knowingly caused wound care centers to bill Medicare for hyperbaric oxygen therapies that were medically unnecessary and unreasonable.
The allegations stem from two whistleblower lawsuits, one filed by a former director for research and quality at Healogics and another filed by several doctors and employees at Healogics-affiliated wound care centers.
“Medicare beneficiaries are entitled to care based on their clinical needs and not the financial goals of healthcare providers,” said Chad Readler, the Justice Department’s … read full article
Healogics to Host Scientific Symposium on Diabetic Wound Healing Innovations
The Healogics symposium will include an overview of diabetic wound identification, prevention and care, and a discussion on leveraging data to improve wound care.
JACKSONVILLE, Fla., June 19, 2018 /PRNewswire/ — Healogics, Inc., the foremost advanced wound care services provider for hospitals, is honored to be hosting a scientific symposium entitled Innovations in Diabetic Wound Healing at the American Diabetes Association 78th Scientific Sessions. The symposium will be taking place on Saturday, June 23 in Orlando, Florida.
The symposium will be led by Healogics Chief Medical Officer, Dr. William Ennis and Organogenesis Vice President of Global and Medical Affairs, Dr. Shabnam Vaezzadeh. There will be presentations from Healogics Medical Director, Dr. Jaime Wise, the Founder and President of the “Save A Leg, Save A Life” Foundation, Dr. Desmond Bell and the Medical Director of the Acute Care Orthopedic Program at Genesis Hospital, Dr. Amy Tucker. The symposium will include an overview of diabetic wound identification, prevention and care, and a discussion on leveraging data to improve wound care. Data will also be shared on wound healing outcomes of more than half a million wounds treated in Healogics outpatient clinics. The use of machine learning and predictive analytics in diabetic wound care will also be discussed … read more
Healogics Shines a Light on Chronic Wounds with Fifth Annual Wound Care Awareness Week
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Healogics, Inc., the nation’s leading provider of advanced wound care services, is proud to sponsor the fifth annual Wound Care Awareness Week from June 4 to June 8, 2018. Throughout this week, Healogics team members from around the country will be working together to shed light on the chronic wound epidemic and bring awareness to the advanced wound care options available. Unfortunately, the incidence of chronic wounds is only expected to rise over the next decade, making awareness and advanced wound care more important now than ever before.
Chronic wounds affect approximately 6.7 million people in the U.S. and an excess of $50 billion is spent annually on treatment. The prevalence of chronic wounds is growing in tandem with an aging population and increasing rates of diseases such as diabetes and peripheral arterial disease, and conditions like obesity and the late effects of radiation therapy. Untreated, chronic wounds can lead to diminished quality of life and possibly amputation of the affected limb. It is in this context that Healogics also created the Wound Science Initiative – a collaborative effort to educate and engage key stakeholders in government and across the healthcare system on the poorly understood and underserved needs of people with non-healing wounds.
About Healogics
Headquartered in Jacksonville, Fla., Healogics and its affiliated companies manage a network of 700 outpatient Wound Care Centers® across the United States and multiple locations in the United Kingdom. Healogics currently has more than 3,000 employees, including nearly 300 employed providers (Healogics Specialty Providers). In addition to the company’s network of outpatient Wound Care Centers, Healogics providers partner with over 400 skilled nursing facilities to care for patients with chronic wounds. More than 300,000 patients were treated by Healogics providers in 2017. For additional information, please visit Healogics.com.
Contacts
Healogics, Inc.
Leslie Niblock, 904-524-2695
Director, Corporate Communications
Leslie.Niblock@healogics.com
Current challenges and opportunities in wound care
3 CNOs weigh in
Wound care costs the U.S. healthcare system an estimated $50 billion annually. The large fiscal burden suggests wound care may be an overlooked target for quality improvement and cost reduction initiatives, according to Jacksonville, Fla.-based Healogics, the nation’s largest provider of advanced wound care services.
More than 30 million diabetics and 28.4 million individuals with heart disease reside in the U.S. Both morbidities represent public health epidemics and carry a heightened risk for chronic wound development. Approximately 6.7 million Americans are afflicted with chronic, non-healing wounds. This figure does not account for wounds attributable to conditions such as necrotizing fasciitis and surgical wounds related to the operating room. The Healogics team asserts that these numbers suggest America is experiencing a chronic wound epidemic.
On April 11, at Becker’s Hospital Review 9th Annual Meeting in Chicago, Arti Masturzo, MD, executive vice president of clinical innovation with Healogics, led a group of hospital leaders in a discussion on current challenges and opportunities related to wound care … read more
Healogics, Inc. Names Allan Woodward
MBA as New Chief Financial Officer
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Healogics, the nation’s largest provider of advanced chronic wound care services, today announced that it has appointed Allan Woodward to serve as Chief Financial Officer. In this role, Woodward will be responsible for the planning and oversight of the financial strategy for the company, the ongoing development of appropriate control systems and all reporting measures. Woodward will report directly to the Chief Executive Officer, David Bassin.
“Allan’s extensive experience in financial leadership roles, combined with his knowledge of the healthcare industry makes him an invaluable asset to our team. We are thrilled to welcome him as our new CFO,” said Bassin.
Over the course of his career, Allan has held several financial leadership roles in healthcare-based organizations. His most recent experience includes his service at eviCore Healthcare as the Senior Vice President of Finance and Strategy over the post-acute care and consumer engagement programs. He was responsible for all financial activities of the business unit, including the creation of financial structures for all product expansions and the development of alternative provider reimbursement initiatives.
Woodward earned his MBA from the University of Missouri and his Bachelor of Science from Middle Tennessee State University … read more
Healogics, Inc. Names David Bassin as New Chief Executive Officer
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Healogics, Inc., the nation’s largest provider of advanced wound care services, today announced that it has appointed David Bassin to serve as Chief Executive Officer. Bassin joined Healogics in January 2016 as Chief Financial Officer.
“David has been an instrumental member of the executive leadership team and a catalyst for change within the organization,” said John Dineen, Chairman of the Board. Dineen went on to say, “David’s extensive leadership experience within healthcare, coupled with his understanding of the Healogics business, makes him uniquely qualified for this CEO role.”
David Bassin, Chief Executive Officer
Prior to Healogics, Bassin served as Chief Financial Officer at eviCore Healthcare, Inc., MedSolutions, Inc., and inVentiv Health, Inc. Over the course of his 20-year career, he has had the opportunity to touch many areas of healthcare, including clinical services, product management, payer strategies and, with Healogics, physician practice management. “His proven track record of driving company growth through strategic initiatives, acquisitions and operational efficiencies will allow him to seamlessly transition into this role. I am delighted that he has accepted this position,” said Dineen.
“I am excited by the opportunity to lead Healogics. It is an honor; and I’m grateful to the Board of Directors for this opportunity,” said David Bassin. “We have an exceptional organization of dedicated and talented professionals. It’s our people that make Healogics a special company and the preeminent provider of wound care. Together, with our hospital partners, we are making an incredible difference in the lives of our patients every day. This is truly an exciting time to be part of Healogics and to lead the company into the future of healthcare.”
“We are incredibly fortunate to have an executive like David leading Healogics